In today’s recent session, 0.44 million shares of the Novavax, Inc (NASDAQ:NVAX) have been traded, and its beta is 3.11. Most recently the company’s share price was $7.61, and it changed around -$0.08 or -1.04% from the last close, which brings the market valuation of the company to $1.22B. NVAX at last check was trading at a discount to its 52-week high of $23.86, offering almost -213.53% off that amount. The share price’s 52-week low was $3.81, which indicates that the recent value has risen by an impressive 49.93% since then. We note from Novavax, Inc’s average daily trading volume that its 10-day average is 3.37 million shares, with the 3-month average coming to 4.31 million.
Novavax, Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.14. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 2 recommended NVAX as a Hold, whereas 3 deemed it a Buy, and 1 rated it as Underweight.
Novavax, Inc (NASDAQ:NVAX) trade information
Instantly NVAX has been showing red trend so far today with a performance of -1.04% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 8.05 on recent trading dayincreased the stock’s daily price by 5.47%. The company’s shares are currently down -5.35% year-to-date, but still down -4.28% over the last five days. On the other hand, Novavax, Inc (NASDAQ:NVAX) is 2.70% up in the 30-day period. We can see from the shorts that 39.23 million shares have been sold at a short interest cover period of 9.02 day(s).
The consensus price target as assigned by Wall Street analysts is $22, which translates to bulls needing to increase their stock price by 65.41% from its current value. Analyst projections state that NVAX is forecast to be at a low of $14 and a high of $25.
Novavax, Inc (NVAX) estimates and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 25.88%. Novavax, Inc earnings are expected to increase by 81.77% in 2025, but the outlook is positive 67.92% per year for the next five years.
Novavax, Inc (NASDAQ:NVAX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 8.80% of Novavax, Inc shares, and 60.18% of them are in the hands of institutional investors. The stock currently has a share float of 65.99%. Novavax, Inc stock is held by 307.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 10.0599% of the shares, which is about 14.08 million shares worth $178.19 million.
BLACKROCK INC., with 8.4669% or 11.85 million shares worth $149.98 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Dec 31, 2024. The former held 4.79 shares worth $36.64 million, making up 2.98% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 4.15 shares worth around $31.79 million, which represents about 2.58% of the total shares outstanding.
